...
首页> 外文期刊>Cell research. >Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis
【24h】

Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis

机译:二十四个基因的甲基化分布图和十九个基因的一致甲基化行为可能有助于肝细胞癌变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To determine the possible role of the epigenetic mechanisms in carcinogenesis of the hepatocellular carcinoma, we methylation-profiled the promoter CpG islands of twenty four genes both in HCC tumors and the neighboring non-cancerous tissues of twenty eight patients using the methylation-specific PCR (MSP) method in conjunction with the DMA sequencing. In comparison with the normal liver tissues from the healthy donors, it was found that while remained unmethylated the ABL, CAV, EPO, GATA3, LKB1, NEP, NFL, MIS and p27~(Kip1) genes, varying extents of the HCC specific hypermethylation were found associated with the ABO, AR, CSPG2, cyclin al, DBCCR1, GALR2, IRF7, MGMT, MT1A, MYOD1, OCT6, p57~(KIP2), p73, WT1 genes, and demethylation with the MAGEA1gene, respectively. Judged by whether the hypermethylated occurred in HCC more frequently than in their neighboring normal tissues, the hypermethylation status of the AR, DBCCR1, IRF7, OCT6, and p73 genes was considered as the event specific to the latestage, while that the rest that lacked such a distinguished contrast, as the event specific to the early stage of HCC carcinogenesis. Among all the clinical pathological parameters tested for the association with, the hypermethylation of the cyclin al gene was more prevalent in the non-cirrhosis group (P=0. 021) while the hypermethylated p16~(INK4a) gene was more common in the cirrhosis group (P=0.017). The concordant methylation behaviors of nineteen genes, including the four previously studied and their association with cirrhosis has been evaluated by the best subgroup selection method. The data presented in this report would enable us to shape our understanding of the mechanisms for the HCC specific loss of the epigenetic stability of the genome, aswell as the strategy of developing the novel robust methylation based diagnostic and prognostic tools.
机译:为了确定表观遗传机制在肝细胞癌发生中的可能作用,我们使用甲基化特异性PCR(甲基化)对HCC肿瘤和28位患者的邻近非癌组织中的24个基因的启动子CpG岛进行了甲基化分析( MSP)方法结合DMA排序。与健康供体的正常肝组织相比,发现ABL,CAV,EPO,GATA3,LKB1,NEP,NFL,MIS和p27〜(Kip1)基因未甲基化时,HCC特异性超甲基化程度不同发现分别与ABO,AR,CSPG2,细胞周期蛋白,DBCCR1,GALR2,IRF7,MGMT,MT1A,MYOD1,OCT6,p57〜(KIP2),p73,WT1基因相关联,并与MAGEA1基因脱甲基相关。根据高甲基化是否在HCC中发生的频率高于其邻近的正常组织,判断AR,DBCCR1,IRF7,OCT6和p73基因的高甲基化状态是特定于最新事件的事件,而其余缺乏这种情况的事件与之形成鲜明对比的是HCC癌变的早期阶段所特有的事件。在所有与之相关的临床病理学参数中,非肝硬化组中cyclin al基因的高甲基化更为普遍(P = 0.021),而肝硬化中p16〜(INK4a)基因的高甲基化更为普遍。组(P = 0.017)。已通过最佳亚组选择方法评估了包括先前研究的四个基因在内的十九个基因的一致甲基化行为及其与肝硬化的关系。本报告中提供的数据将使我们能够形成对HCC基因组表观遗传稳定性的特异性丧失机制的理解,以及开发新型基于鲁棒性甲基化的诊断和预后工具的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号